Vancouver’s Kardium has announced the first clinical use of its new 3D mapping and navigation feature of its flagship product, the Globe Mapping and Ablation System.
The Globe Positioning System (GPS™) is for the treatment of atrial fibrillation (AF) – the world’s most common heart rhythm disorder.
It is a powerful 122-electrode mapping and ablation system that combines best-in-class technologies into a single catheter, uniting the rapid pulmonary vein isolation (PVI) of balloon catheters, the flexibility of single-tip catheters, and the high-definition mapping of multi-electrode mapping catheters.
The new GPS 3D mapping and navigation feature allows electrophysiologists (EPs) to track the precise position of the Globe Catheter inside the atrium, enabling the creation of full 3D, high-definition maps of the entire atrium. This provides EPs with the ability to create a detailed atrial map to identify additional targets for ablation, and then immediately ablate them – all with a single catheter.
“The Globe Mapping and Ablation System now provides EPs with the ultimate in high-definition mapping,” added Kevin Chaplin, Kardium CEO. “The GPS feature allows EPs to quickly map the whole atrium, providing detailed information that allows them to decide on the best treatment for the patient. They can then treat the patient with the appropriate ablation, using the same catheter. This is going to help reduce procedure times while also improving the effectiveness of the procedure for each patient.”